Debt-to-equity of CATALYST PHARMACEUTICALS, INC. from 31 Mar 2012 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's debt by its shareholder equity.
- Summary
-
CATALYST PHARMACEUTICALS, INC. quarterly Debt-to-equity in x history and change rate from 31 Mar 2012 to 31 Dec 2025.
- CATALYST PHARMACEUTICALS, INC. Debt-to-equity for the quarter ending 31 Dec 2025 was 0.15x, a 11% decline year-over-year.
Debt-to-equity, Quarterly (x)
Debt-to-equity, YoY Quarterly Change (%)
CATALYST PHARMACEUTICALS, INC. Quarterly Debt-to-equity (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 0.15x | -0.02x | -11% | 31 Dec 2025 |
| Q3 2025 | 0.15x | -0.02x | -13% | 30 Sep 2025 |
| Q2 2025 | 0.15x | -0.02x | -12% | 30 Jun 2025 |
| Q1 2025 | 0.16x | -0.02x | -11% | 31 Mar 2025 |
| Q4 2024 | 0.16x | -0.04x | -18% | 31 Dec 2024 |
| Q3 2024 | 0.17x | -0.04x | -18% | 30 Sep 2024 |
| Q2 2024 | 0.17x | -0.05x | -21% | 30 Jun 2024 |
| Q1 2024 | 0.18x | -0.03x | -14% | 31 Mar 2024 |
| Q4 2023 | 0.2x | +0.01x | +7.9% | 31 Dec 2023 |
| Q3 2023 | 0.21x | +0.05x | +33% | 30 Sep 2023 |
| Q2 2023 | 0.22x | +0.09x | +75% | 30 Jun 2023 |
| Q1 2023 | 0.21x | +0.08x | +65% | 31 Mar 2023 |
| Q4 2022 | 0.19x | +0.06x | +52% | 31 Dec 2022 |
| Q3 2022 | 0.16x | +0.04x | +34% | 30 Sep 2022 |
| Q2 2022 | 0.13x | +0.01x | +8.9% | 30 Jun 2022 |
| Q1 2022 | 0.13x | -0x | -2.8% | 31 Mar 2022 |
| Q4 2021 | 0.12x | -0.03x | -17% | 31 Dec 2021 |
| Q3 2021 | 0.12x | -0.06x | -35% | 30 Sep 2021 |
| Q2 2021 | 0.11x | -0.1x | -47% | 30 Jun 2021 |
| Q1 2021 | 0.13x | -0.1x | -44% | 31 Mar 2021 |
| Q4 2020 | 0.15x | -0.1x | -39% | 31 Dec 2020 |
| Q3 2020 | 0.18x | -0.04x | -18% | 30 Sep 2020 |
| Q2 2020 | 0.22x | +0.05x | +31% | 30 Jun 2020 |
| Q1 2020 | 0.23x | +0.12x | +109% | 31 Mar 2020 |
| Q4 2019 | 0.24x | +0.17x | +229% | 31 Dec 2019 |
| Q3 2019 | 0.22x | +0.17x | +352% | 30 Sep 2019 |
| Q2 2019 | 0.17x | +0.11x | +222% | 30 Jun 2019 |
| Q1 2019 | 0.11x | +0.06x | +103% | 31 Mar 2019 |
| Q4 2018 | 0.07x | +0.01x | +13% | 31 Dec 2018 |
| Q3 2018 | 0.05x | -0.02x | -32% | 30 Sep 2018 |
| Q2 2018 | 0.05x | -0.01x | -17% | 30 Jun 2018 |
| Q1 2018 | 0.05x | -0.01x | -11% | 31 Mar 2018 |
| Q4 2017 | 0.07x | +0.01x | +11% | 31 Dec 2017 |
| Q3 2017 | 0.07x | +0.01x | +8.1% | 30 Sep 2017 |
| Q2 2017 | 0.06x | -0x | -7.1% | 30 Jun 2017 |
| Q1 2017 | 0.06x | -0.01x | -18% | 31 Mar 2017 |
| Q4 2016 | 0.06x | -0.04x | -38% | 31 Dec 2016 |
| Q3 2016 | 0.07x | -0.06x | -46% | 30 Sep 2016 |
| Q2 2016 | 0.07x | -0.1x | -59% | 30 Jun 2016 |
| Q1 2016 | 0.08x | -0.1x | -58% | 31 Mar 2016 |
| Q4 2015 | 0.1x | -0.11x | -54% | 31 Dec 2015 |
| Q3 2015 | 0.12x | -0.07x | -37% | 30 Sep 2015 |
| Q2 2015 | 0.16x | -0.03x | -16% | 30 Jun 2015 |
| Q1 2015 | 0.18x | -0.07x | -29% | 31 Mar 2015 |
| Q4 2014 | 0.21x | -0.02x | -6.8% | 31 Dec 2014 |
| Q3 2014 | 0.19x | -0.03x | -12% | 30 Sep 2014 |
| Q2 2014 | 0.19x | -0x | -0.39% | 30 Jun 2014 |
| Q1 2014 | 0.25x | +0.07x | +41% | 31 Mar 2014 |
| Q4 2013 | 0.22x | -0.03x | -12% | 31 Dec 2013 |
| Q3 2013 | 0.22x | -0.18x | -44% | 30 Sep 2013 |
| Q2 2013 | 0.2x | -0.19x | -50% | 30 Jun 2013 |
| Q1 2013 | 0.18x | -0.2x | -53% | 31 Mar 2013 |
| Q4 2012 | 0.25x | 31 Dec 2012 | ||
| Q3 2012 | 0.39x | 30 Sep 2012 | ||
| Q2 2012 | 0.39x | 30 Jun 2012 | ||
| Q1 2012 | 0.38x | 31 Mar 2012 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.